Neurofibrillary tangles are one of the hallmarks of Alzheimer's Disease (AD). These aggregated bundles of protein products, known as tau proteins, are composed of twisted filaments constructed from different parts of the microtubule subunits. They are responsible for keeping the neurons connected to each other but over time, due to the accumulation of these proteins and other molecules, they begin to bind together and disrupt the structure of the neurons. Ultimately, this leads to the death of the neuron and the disintegration of its connections to the rest of the nervous system. The formation of neurofibrillary tangles can have a number of causes, including genetic mutations, environmental factors, and aging. For example, mutations of the tau protein can cause hyperphosphorylation, a process where an enzyme modifies the amino acid sequence of the tau protein. This increases the tendency of the protein to aggregate, leading to the formation of neurofibrillary tangles. Similarly, environmental factors, such as exposure to certain chemicals, can also increase the likelihood of hyperphosphorylation and tangle formation. In addition, aging can also play a role in how common neurofibrillary tangles are. As people get older, the proteins responsible for removing tangle-forming molecules from the neuronal pathways succumb to age-related wear and tear, leading to an increase in tau proteins and the formation of neurofibrillary tangles. Neurofibrillary tangles are not exclusive to Alzheimer's Disease but can also be found in other neurodegenerative diseases, such as Parkinson's disease, progressive supranuclear palsy, Pick's disease, and Huntington's disease. In these cases, they are associated with the breakdown of the connections between neurons and other cellular components. In spite of this, the presence of tangle bundles is still thought to be the most reliable marker for the diagnosis of AD, as it is one of the few neuropathologic changes that can be detected with certainty.
Title : Scalp acupuncture with functional electrical stimulation for the treatment children with autism spectrum disorder
Zhenhuan Liu, Guangzhou University of Chinese Medicine, China
Title : Perception and individuality in patient cases identifying the ongoing evolution of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)
Ken Ware, NeuroPhysics Therapy, Australia
Title : A structure-based strategy to target pathogenic α-synuclein in Parkinson’s disease
Salvador Ventura, Autonomous University of Barcelona, Spain
Title : Rabies: Challenges in taming the beast
Alan C Jackson, University of Calgary, Canada
Title : Designing and managing intelligent and ethical transformed health and social care ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Understanding Alzheimer's disease biomarkers across diverse populations - Opportunities and Insights for novel prevision medicine approaches
Sid O Bryant, Texas College of Osteopathic Medicine and University of North Texas Health Science Center Fort Worth, United States